Results 211 to 220 of about 10,302,641 (371)

Precise Regulation of Membrane Proteins: From Physical Technology to Biomolecular Strategy

Advanced Science, EarlyView.
This review summarizes the emerging strategies for the precise regulation of membrane proteins using physical stimuli and biomolecule‐based tools. These methods provide new insights into cell regulation and offer promising directions for future disease treatment.
Xiu Zhao, Qingqing Zhou, Mengli Li, Wen Zou, Zhenzhong Zhang, Jinjin Shi, Junjie Liu   +6 more
wiley   +1 more source

From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease. [PDF]

Korean J Intern Med
Siddappa PK, Kong N, Lee A, Jiang Y, Park WG.   +4 more
europepmc   +1 more source

Positive Feedback Loop of Histone Lactylation‐Driven HNRNPC Promotes Autophagy to Confer Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance

Advanced Science, EarlyView.
Histone 3 lysine18 lactylation (H3K18la) drives heterogeneous nuclear ribonucleoprotein C (HNRNPC) overexpression, activating autophagy to mediate gemcitabine resistance by stabilizing TNF receptor‐associated factor 6 (TRAF6) mRNA. Concurrently, HNRNPC stabilizes aldehyde dehydrogenase 1 family member A3 (ALDH1A3) mRNA, which enhances glycolysis and ...
Xi‐Tai Huang, Jiao Chen, En‐Liang Zhu, Ming‐Jian Ma, Yang‐Yin‐Hui Yu, Ying‐Qin Zhu, Jing‐Yuan Ye, Jin‐Zhao Xie, Zi‐Yi Zhao, Xiao‐Yu Yin   +9 more
wiley   +1 more source

CT findings in surgically treated focal pancreatic disease - a retrospective study. [PDF]

Ann Med Surg (Lond)
Zurek Munk-Madsen M, Ewertsen C, Hansen CP, Axelsen T, Kristensen TS.   +4 more
europepmc   +1 more source

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

New England Journal of Medicine, 2013
D. V. Von Hoff, T. Ervin, F. Arena, E. Chiorean, J. Infante, M. Moore, T. Seay, S. Tjulandin, W. Ma, M. Saleh, M. Harris, M. Reni, S. Dowden, D. Laheru, N. Bahary, R. Ramanathan, J. Tabernero, M. Hidalgo, D. Goldstein, E. Van Cutsem, Xinyu Wei, J. Iglesias, M. Renschler   +22 more
semanticscholar   +1 more source

Targeting NRP1 in Endothelial Cells Facilitates the Normalization of Scar Vessels and Prevents Fibrotic Scarring

Advanced Science, EarlyView.
Scars exhibit vascular abnormal alterations, including upregulated NRP1 expression in endothelial cells, increased vascular density and branching, compromised vessel wall integrity, and incomplete pericyte coverage. Therapeutic targeting of NRP1 through hydrogel spray delivery offers a promising approach to normalize aberrant vasculature and prevent ...
Yu Wang, Xin Zhou, Min Liu, Meimei Huang, Peirong Chen, Xinying Li, Fangchao Xue, Wenyan Zhao, Di Liu, Lang Li, Yuangang Lu, Wen Zeng   +11 more
wiley   +1 more source

High-risk factors for postoperative complications in patients with pancreatic disease: a single-center experience. [PDF]

Front Surg
Zhang M, Li N, Tian W, Xiao Q, Wei K, Wang Z, Lu H.   +6 more
europepmc   +1 more source

Imaging Findings of Pancreatic Cystic Lesions in von Hippel-Lindau Disease

, 2012
Noritoshi Kobayashi, Takamitsu Sato, Shingo Kato, Seitaro Watanabe, Kunihiro Hosono, Takeshi Shimamura, Hiroshi Iida, Hiroki Endo, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Wataru Shibata, Yasunobu Abe, Masahiko Inamori, Hiroyuki Kirikoshi, Satoru Saito, Shin Maeda, Atsushi Nakajima, Kensuke Kubota   +18 more
openalex   +2 more sources

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

Advanced Science, EarlyView.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang, Qian Shen, Yao Lin, Jing Zhu, Xiaolan Zhu, Rui Huang, Yijia Wu, Feiyang Shen, Qian Li, Guopei Zheng, Zhe Zhang, Qian Chu, Junhao Hu, Jianfeng Shen   +13 more
wiley   +1 more source

PANCREATIC DISEASE [PDF]

Gut, 2001
openaire   +2 more sources